Wells Fargo & Company Orgenesis Inc. Transaction History

Wells Fargo & Company

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.28 - $0.9 $7 - $23	26 Added 12.04%	242 $0
Q4 2023 Feb 09, 2024	BUY	$0.44 - $0.96 $10 - $22	23 Added 11.92%	216 $0
Q3 2023 Nov 13, 2023	BUY	$0.41 - $1.4 $1 - $4	3 Added 1.58%	193 $0
Q2 2023 Aug 15, 2023	BUY	$1.01 - $1.44 $26 - $37	26 Added 15.85%	190 $0
Q1 2023 May 12, 2023	BUY	$1.18 - $2.59 $2 - $5	2 Added 1.23%	164 $0
Q4 2022 Feb 13, 2023	BUY	$1.18 - $2.24 $10 - $20	9 Added 5.88%	162 $0
Q3 2022 Nov 14, 2022	BUY	$1.38 - $2.38 $6 - $11	5 Added 3.38%	153 $0
Q2 2022 Aug 12, 2022	BUY	$1.8 - $3.74 $27 - $56	15 Added 11.28%	148 $0
Q1 2022 May 16, 2022	SELL	$2.31 - $3.72 $1,039 - $1,674	-450 Reduced 77.19%	133 $0
Q4 2021 Feb 14, 2022	SELL	$2.61 - $4.9 $2 - $4	-1 Reduced 0.17%	583 $1,000
Q3 2021 Nov 15, 2021	SELL	$4.6 - $5.44 $23 - $27	-5 Reduced 0.85%	584 $3,000
Q2 2021 Aug 16, 2021	SELL	$4.19 - $5.88 $603,380 - $846,749	-144,005 Reduced 99.59%	589 $3,000
Q1 2021 May 13, 2021	BUY	$4.77 - $8.08 $464,488 - $786,806	97,377 Added 206.23%	144,594 $829,000
Q4 2020 Feb 09, 2021	BUY	$4.4 - $5.63 $18,132 - $23,201	4,121 Added 9.56%	47,217 $212,000
Q3 2020 Nov 05, 2020	BUY	$4.75 - $5.99 $53,831 - $67,884	11,333 Added 35.68%	43,096 $217,000
Q2 2020 Aug 13, 2020	BUY	$3.6 - $7.84 $114,051 - $248,379	31,681 Added 38635.37%	31,763 $194,000
Q1 2020 May 14, 2020	BUY	$2.76 - $5.44 $226 - $446	82 New	82 $0

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.